메뉴 건너뛰기




Volumn 121, Issue 6, 2002, Pages 1733-1735

Challenges of treating latent tuberculosis infection

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

EID: 0036282637     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.121.6.1733     Document Type: Editorial
Times cited : (4)

References (15)
  • 3
    • 0034091974 scopus 로고    scopus 로고
    • Targeted tuberculin testing and treatment of latent tuberculosis infection
    • (2000) Am J Respir Crit Care Med , vol.161
  • 12
    • 0007487795 scopus 로고    scopus 로고
    • Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: An international randomized trial
    • (2000) JAMA , vol.283 , pp. 1445-1450
    • Gordin, F.1    Chaisson, R.E.2    Matts, J.P.3
  • 13
    • 9844267960 scopus 로고    scopus 로고
    • A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus; Uganda-Case Western Reserve University Research Collaboration
    • (1997) N Engl J Med , vol.337 , pp. 801-808
    • Whalen, C.C.1    Johnson, J.L.2    Okwera, A.3
  • 14
    • 0035482828 scopus 로고    scopus 로고
    • Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC Recommendations-United States, 2001
    • (2001) Am J Respir Crit Care Med , vol.164 , pp. 1319-1320


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.